RARRES2 and metabolic disease: Since the latter finding implies a rather transient nature of the observed decline, it should motivate future longitudinal approaches in order to investigate circulating chemerin kinetics during long-term periods of conservative and surgical obesity therapy in relation to sustained weight loss and improvement in metabolic disorders.